Gastroenterology

Gastroenterology

Volume 151, Issue 5, November 2016, Pages 836-844
Gastroenterology

Reviews and Perspectives
Brief Review
The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System

https://doi.org/10.1053/j.gastro.2016.07.044Get rights and content
Under a Creative Commons license
open access

The gastrointestinal (GI) tract is essential for the absorption of nutrients, induction of mucosal and systemic immune responses, and maintenance of a healthy gut microbiota. Key aspects of gastrointestinal physiology are controlled by the enteric nervous system (ENS), which is composed of neurons and glial cells. The ENS is exposed to and interacts with the outer (microbiota, metabolites, and nutrients) and inner (immune cells and stromal cells) microenvironment of the gut. Although the cellular blueprint of the ENS is mostly in place by birth, the functional maturation of intestinal neural networks is completed within the microenvironment of the postnatal gut, under the influence of gut microbiota and the mucosal immune system. Recent studies have shown the importance of molecular interactions among microbiota, enteric neurons, and immune cells for GI homeostasis. In addition to its role in GI physiology, the ENS has been associated with the pathogenesis of neurodegenerative disorders, such as Parkinson’s disease, raising the possibility that microbiota–ENS interactions could offer a viable strategy for influencing the course of brain diseases. Here, we discuss recent advances on the role of microbiota and the immune system on the development and homeostasis of the ENS, a key relay station along the gut–brain axis.

Keywords

Enteric Nervous System (ENS)
Microbiota
Neuroimmune Interaction
Parkinson’s Disease
Microbiota–Gut–Brain Axis

Abbreviations used in this paper

BMP
bone morphogenetic protein
BSH
bile salt hydrolase
CNS
central nervous system
EC
enterochromaffin cell
EGC
enteric glial cell
ENS
enteric nervous system
GF
germ-free
GLP-1
glucagon-like peptide-1
GI
gastrointestinal
5-HT
5-hydroxytryptamine
IBS
irritable bowel syndrome
MCT
monocarboxylate transporter
MGB
microbiota–gut–brain
MM
muscularis macrophage
nNOS
neuronal nitric oxide synthase
PD
Parkinson’s disease
RSD
resistant starch diet
SCFA
short-chain fatty acid
SERT
serotonin-selective reuptake transporter
TLR
Toll-like receptor

Cited by (0)

Conflicts of interest The authors disclose no conflicts.

Funding Work in Vassilis Pachnis's laboratory is funded by the Francis Crick Institute and the BBSRC (Biotechnology and Biological Sciences Research Council). Also supported by a long-term EMBO (European Molecular Biology Organization) fellowship (Y.O.).